Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice (Q35050420)

6 August 2017

Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice (English)

1 reference

6 August 2017

0 references

Paas-Rozner M

1

1 reference

6 August 2017

Dayan M

2

1 reference

6 August 2017

Paas Y

3

1 reference

6 August 2017

Changeux JP

4

1 reference

6 August 2017

Wirguin I

5

1 reference

6 August 2017

Sela M

6

1 reference

6 August 2017

Mozes E

7

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

Proceedings of the National Academy of Sciences of the United States of America

6 August 2017

1 reference

6 August 2017

97

1 reference

6 August 2017

5

1 reference

6 August 2017

2168-2173

1 reference

Single amino acid analogs of a myasthenogenic peptide modulate specific T cell responses and prevent the induction of experimental autoimmune myasthenia gravis

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Altered peptide ligands of a myasthenogenic epitope as modulators of specific T-cell responses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

The immunogenetics of myasthenia gravis, multiple sclerosis and their animal models

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Fine specificity of T cell lines and clones that are capable of inducing autoimmune manifestations in mice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Experimental myasthenia gravis. A murine system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Autoimmune Response to Acetylcholine Receptor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automim

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=15772

Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases

8 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.040554597

Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.040554597

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.040554597

Suppression of cellular and humoral immunity to T-dependent antigens by calorie restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.040554597

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.040554597

Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.040554597

Production of interferon gamma and interleukin-2 by peripheral blood lymphocytes of patients with myasthenia gravis and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.040554597

Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.040554597

Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.040554597

Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.040554597

HLA-DQ beta-chain polymorphism linked to myasthenia gravis

21 January 2018

1 reference

12 December 2020

The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit

1 reference

12 December 2020

Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis

1 reference

12 December 2020

Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis

1 reference

12 December 2020

Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells

1 reference

12 December 2020

Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.040554597

1 reference

6 August 2017

0 references

1 reference

6 August 2017

1 reference